阿奇霉素与甲泼尼龙联合治疗小儿难治性支原体肺炎的临床疗效分析

Analysis of Clinical Efficacy of Azithromycin Combined With Methylprednisolone Treatment in Children With Refractory Mycoplasma Pneumonia

目的探讨阿奇霉素与甲泼尼龙联合治疗小儿难治性支原体肺炎中的效果。方法选取难治性支原体肺炎患者75例,按随机数字表法分为对照组37例(阿奇霉素治疗),观察组38例(阿奇霉素联合甲泼尼龙治疗)。结果观察组患者治疗有效率为94.74%,高于对照组患者的81.08%,差异具有统计学意义(P<0.05);两组患者不良反应发生率无显著差异(P>0.05)。结论阿奇霉素联合甲泼尼龙治疗小儿难治性支原体肺炎效果显著。

Objective To investigate the azithromycin and methylprednisolone combination therapy in children with refractory mycoplasma pneumonia in effect. Methods 75 cases with refractory mycoplasma pneumonia were randomly divided into a control group of 37 patients （azithromycin）, the observation group 38 cases （azithromycin methylprednisolone therapy）. Results The effective rate of the observation group was 94.74%, higher than that of the control group of 81.08%, the difference was statistically significant （P〈0.05）, two groups of patients the incidence of adverse reactions was no signiifcant difference （P〉0.05）. Conclusion Azithromycin methylprednisolone therapy for refractory mycoplasma pneumonia in children is remarkable.